Cardiac enzymes are essential indicators in the assessment of heart health, providing valuable insights into cardiac conditions. These enzymes, including myoglobin, creatine kinase-MB (CK-MB), and aspartate aminotransferase (AST), serve as sensitive markers for myocardial damage. Elevated levels of these enzymes in the bloodstream can signal various cardiac issues, such as myocardial infarction or angina. Among them, CK-MB is particularly specific to heart muscle, aiding in the accurate diagnosis of heart-related disorders. The measurement and interpretation of cardiac enzyme levels empower healthcare professionals to make informed decisions, facilitating early detection and intervention in cardiac emergencies. Understanding the nuances of different cardiac enzymes enhances the precision of cardiovascular diagnostics, contributing to more effective patient care.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation